Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 161-168

  Subramaniam, Swaminathan ^a,b   Donevan, Sean D ^a   Rogawski, Michael A ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b DR REDDY S RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIZOCILPINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REMACEMIDE;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING AFFINITY; BRAIN ISCHEMIA; DRUG POTENCY; ENANTIOMER; LIGAND BINDING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEIZURE; STEREOSPECIFICITY; VOLTAGE CLAMP;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; BINDING SITES; CELLS, CULTURED; DIZOCILPINE MALEATE; HIPPOCAMPUS; KINETICS; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PHENETHYLAMINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RECEPTORS, N-METHYL-D-ASPARTATE; SPERMINE; TRITIUM;

EID: 0029670420     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BANNAN, P. E., GRAHAM, D. I., LEES, K. R. AND McCULLOCH, J.: Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat. Brain Res. 664: 271-275, 1994.
2. BENEVENISTE, M. AND MAYER, M. L.: Multiple effects of spermine on n-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurones. J. Physiol. (Lond.) 464: 131-163, 1993.
3. BOTTENSTEIN, J. E.: Growth and differentiation of neuronal cells in defined media. In Cell Culture in the Neurosciences, ed. by J. E. Bottenstein and G. Sato, pp. 3-14, Plenum Press, New York, 1985.
4. CRAMER, C. L., STAGNITTO, M. L., KNOWLES, M. A., PALMER, G. C.: Kainic acid and 4-aminopyridine seizure models in mice: Evaluation of efficacy of antiepileptic agents and calcium antagonists. Life Sci. 54: PI271-PI275, 1994.
5. DONEVAN, S. D. AND ROGAWSKI, M. A.: GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10: 51-69, 1993.
6. GARSKE, G. E., PALMER, G. C., NAPIER, J. J., GRIFFITH, R. C., FREEDMAN, L. R., HARRIS, E. W., RAY, R., McCREEDY, S. A., BLOSSER, J. C., WOODHEAD, J. H., WHITE, H S. AND SWINYARD, E. A.. Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat. Epilepsy Res. 9: 161-174, 1991.
7. GUTHRIE, P. B., BRENNEMAN, D. E. AND NEALE, E. A.: Morphological and biochemical differences expressed in separate dissociated cell cultures of dorsal and ventral halves of the mouse spinal cord. Brain Res. 420: 313-323, 1987.
8. HARRIS, E., STAGNITTO, M., GARSKE, G., CREGAN, E., RAY, R., JULIEN, R., WILSON, T., MACHULSKIS, G., BIALOBOK, P., WHITE, J. AND PALMER, G.: Neuroprotection by remacemide, a prodrug for noncompetitive NMDA antagonism with a high therapeutic index. In Multiple Sigma and PCP Ligands: Mechanism for Neuromodulation and Neuroprotection?, ed. by J.-M. Kamenka and E. F. Domino, pp. 643-653, NPP Books, Ann Arbor, MI, 1992.
9. HEYN, H., MCCARTHY, D. J., CURRY, S. H., EISMAN, M. S. AND ANDERS, M. W.: Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant. Drug Metab. Dispos. 22: 443-446, 1994.
10. HUETTNER, J. E. AND BEAN, B. P.: Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc. Natl. Acad. Sci. U.S.A. 85: 1307-1311, 1988
11. 3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. Mol. Pharmacol. 35: 387-393, 1989
12. 3H]Dizocilpine association kinetics distinguish stimulatory and inhibitory polyamine sites of N-methyl-D-aspartate receptors. J. Neurochem 63: 963-971, 1994.
13. 2+ of NMDA responses in spinal cord neurones. Nature 309: 261-263, 1984.
14. MCBAIN, C. J. AND MAYER, M. L.: N-Methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74: 723-760, 1994.
15. NOWAK, L., BREGESTOVSKI, P., ASCHER, P., HERBET, A. AND PROCHIANTZ, A.: Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307: 462-465, 1984.
16. ORDY, J. M., VOLPE, B., MURRAY, R., THOMAS, G., BIALOBOK, P., WENGENACK, T. M. AND DUNLAP, W.: Pharmacological effects of remacemide and MK-801 on memory and hippocampal CA1 damage in the rat four-vessel occlusion (4-VO) model of global ischemia. In The Role of Neurotransmitters in Brain Injury, ed. by M. Y.-T Globus and W D. Dietrich, pp. 83-92, Plenum Press, NY, 1992.
17. PALMER, G. C., CLARK, B. AND HUTCHISON, J. B.: Antiepeileptic and neuroprotective potential of remacemide hydrochloride. Drugs Future 18: 1021-1042, 1993.
18. PALMER, G. C., MURRAY, R. J., WILSON, T. C. M., EISMAN, M. S., RAY, R. K., GRIFFITH, R. C., NAPIER, J. J., FEDORCHUK, M., STAGNITTO, M. L. AND GARSKE, G. E.: Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide. Epilepsy Res. 12: 9-20, 1992.
19. REYNOLDS, I. J. AND MILLER, R. J.: Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol. Pharmacol. 33: 581-584, 1988.
20. ROGAWSKI, M. A.: The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report. Drugs 44: 279-292, 1992.
21. SCHEYER, R. D., CRAMER, J. A., LEPPIK, I E., PELLOCK, J. M , HOCHHOLZER, J. M., SPENCER, M., OHARA, K AND MUIR, K. T.: Remacemide elimination after initial and chronic dosing Clin. Pharmacol. Ther. 51: 189, 1992.
22. STAGNITTO, M. L , PALMER, G. C., ORDY, M. J., GRIFFITH, R. C., NAPIER, J J., BECKER, C N., GENTILE, R. J., GASSKE, G E., FRANKENHEIM, J. M , WOODHEAD, J. H., WHITE, S. H. AND SWINYARD, E. A.: Preclinical profile of remacemide: A novel anticonvulsant effective against maximal seizures in mice. Epilepsy Res. 7: 11-28, 1990.
23. SUBRAMANIAM, S., DONEVAN, S. D. AND ROGAWSKI, M A.: Hydrophobic interactions of n-alkyl diamines with the NMDA receptor: Voltage-dependent and -independent blocking sites. Mol. Pharmacol. 45: 117-124, 1994.
24. SUBRAMANIAM, S. AND MCGONIGLE, P.: Regional heterogeneity of polyamine effects on the N-methyl-D-aspartate receptor in rat brain. J. Neurochem. 60: 2276-2284, 1993.
25. SUBRAMANIAM, S., RHO, J. M., PENIX, L., DONEVAN, S. D , FIELDING, R. P. AND ROGAWSKI, M. A.: Felbamate block of the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 273: 878-886, 1995.
26. WAMIL, A W., MCLEAN, M. J., CHEUNG, H. AND HARRIS, E : Remacemide and its desglycinated metabolite limit sustained high-frequency repetitive firing of action potentials of mouse central neurons in-vitro. Epilepsia 33 (Suppl. 3): 84, 1992.
27. WILSON, T. C. M., MACHULSKIS, G. E., GARSKE, G. E. AND HARRIS, E. W.: Anticonvulsant concentrations in CSF and serum of rats protected against MES by PR934-423A. Soc. Neurosci. Abst. 14: 1034, 1988.
28. WOODHULL, A. M.: Ionic blockage of sodium channels in nerve. J Gen. Physiol. 61: 687-708, 1973.